Neoadjuvant Cabozantinib in Treating Patients With Locally Advanced Kidney Cancer

Clinical trial NCT04022343 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04022343
Sponsor: Emory University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Renal Cell Carcinoma Stage III Renal Cell Cancer AJCC v8

Start date: 2019-08-06
Primary completion: 2022-02-02
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.